CClinicalTrials.gg
CompletedNCT02118883Updated Jul 16, 2014

Dehydration, Rehydration, and Blood Viscosity

An interventional study of Essentia Water and Bottled water in Dehydration, sponsored by Essentia Water, LLC. Completed at 1 site in United States. Open to participants aged 25 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-07-16.

Sponsored by Essentia Water, LLC · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
25 Years to 49 Years
Sex
All
01

Study summary

The purpose of this study is to examine and compare the rehydration effect of Essentia Water, an electrolyzed high-pH bottled water, with industry-standard bottled water purified by reverse osmosis with minerals added, on (1) whole blood viscosity, (2) plasma osmolality, (3) bioelectrical impedance analysis, and (4) body mass change, using serial measurements in apparently healthy adults following exercise-induced dehydration in a controlled environment.

02

Conditions studied

  • Dehydration

Browse trials for

Keywords

  • exercise
  • hydration
  • dehydration
  • rehydration
  • alkaline water
  • blood viscosity
  • plasma osmolality
  • bioimpedance
03

In context

Dehydration

204 studies on the registry are indexed under Dehydration; 29 are open to participants now.

This study's enrollment of 100 is above the median of 43 across 147 interventional studies indexed under Dehydration.

Browse Dehydration studies →

Lead sponsor

This is the only study on the registry with Essentia Water, LLC as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 49 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Free from any medication for at least 1 week prior to the study

Exclusion criteria

Exclusion Criteria:

  • Any chronic condition requiring regular treatment or medical follow-up
  • Bleeding disorder or susceptible to prolonged or uncontrolled bleeding
  • Active infection
  • Current smoker
  • Subject has a BMI equal or greater than 30
  • Use of oral contraceptives in the previous 3 months
  • Subject is pregnant or breast-feeding
  • Currently menstruating
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
100 participants (actual)

Study arms

  • Other
    Essentia Water

    Essentia Water, electrolyzed high-pH water

    Other: Essentia Water

  • Other
    Bottled Water

    Purified bottle water

    Other: Bottled water

Interventions

  • OtherEssentia Water

    Also known as: Electrolyzed high-pH water

  • OtherBottled water

    Also known as: Purified bottled water

06

What researchers measure

Primary outcomes

  1. Change in whole blood viscosity from dehydrated state

    Blood viscosity measured using a scanning capillary viscometer

    Time frame: 120 min following rehydration

Secondary outcomes

  1. Change in whole blood viscosity from dehydrated state

    Blood viscosity measured using scanning capillary viscometer

    Time frame: 15, 30, 60, and 90 min following rehydration

  2. Change in plasma osmolality from dehydrated state

    Plasma osmolality measured using freezing point osmometer

    Time frame: 15, 30, 60, 90, and 120 min following rehydration

  3. Change in bioelectrical impedance

    Impedance is measured to provide an estimation of body composition using a bioelectrical impedance analyzer (RJL Quantum IV).

    Time frame: 45, 75, and 120 min following rehydration

  4. Body mass change

    Time frame: 45, 75, and 120 min following rehydration

07

Study locations

1 site
  • Health Onvector Inc
    Camden, New Jersey 08103, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02118883
Lead sponsor
Essentia Water, LLC
Collaborators
Health Onvector Inc.
Responsible party
Sponsor
First posted
Apr 21, 2014
Start date
Apr 2014
Primary completion
Jun 2014
Completion
Jul 2014
Last update
Jul 16, 2014

Study contacts

Gregory Fridman, PhD
principal investigator · A.J. Drexel Plasma Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion